Roberto Avellino

Rehovot, M, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Localized PD-1 CAR T therapy reprograms neuroinflammation.

Localized PD-1 CAR T therapy reprograms neuroinflammation.

Journal: Cell
Published: September 07, 2025

Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells.

Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells.

Journal: Cancer cell
Published: June 09, 2025

Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy.

Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy.

Journal: Cell
Published: April 02, 2025

ZEB2 is a master switch controlling the tumor-associated macrophage program.

ZEB2 is a master switch controlling the tumor-associated macrophage program.

Journal: Cancer cell
Published: July 15, 2024

The transcriptional and regulatory identity of erythropoietin producing cells.

The transcriptional and regulatory identity of erythropoietin producing cells.

Journal: Nature medicine
Published: January 23, 2022

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice.

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice.

Journal: Blood advances
Published: July 30, 2021

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Journal: Cell reports
Published: November 14, 2019

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Journal: Cell reports
Published: October 31, 2018

Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.

Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.

Journal: Cancer discovery
Published: September 15, 2016

Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.

Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.

Journal: Blood
Published: September 09, 2016

An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.

An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.

Journal: Blood
Published: January 28, 2016

Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.

Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.

Journal: Nature chemical biology
Published: September 18, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026